Selected article for: "complete resolution and significant resolution"

Author: O’Kelly, Brendan; Mohamed, Aia; Bergin, Colm; Lyons, Fiona; Rogers, Thomas R.; O’Connell, Brian; Devitt, Emma
Title: Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV
  • Cord-id: n0ued0mp
  • Document date: 2021_5_28
  • ID: n0ued0mp
    Snippet: We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the Cryptococcus neoformans isolate from cerebrospinal fluid had a borderline minimum inhibitory concentration of 8 mg/L, initial consolidation therapy was given with a daily dose of fluconazole 1200 mg based on area under the curve to minimum inhibitory concentration modelling data. Toxicity, and
    Document: We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the Cryptococcus neoformans isolate from cerebrospinal fluid had a borderline minimum inhibitory concentration of 8 mg/L, initial consolidation therapy was given with a daily dose of fluconazole 1200 mg based on area under the curve to minimum inhibitory concentration modelling data. Toxicity, and the radiological emergence of a cryptococcoma in the setting of immune reconstitution inflammatory syndrome, prompted a therapeutic switch to isavuconazole. Subsequent imaging after 19 weeks of isavuconazole shows a significant reduction in cryptococcoma size from 11 mm to complete resolution. The patient remains well after 210 days of therapy with a view to completion of treatment after 1 year.

    Search related documents:
    Co phrase search for related documents
    • acute aki kidney injury and adjustment dose: 1, 2
    • acute aki kidney injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute aki kidney injury and long term treatment: 1, 2, 3
    • acute aki kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute aki kidney injury and magnetic resonance: 1, 2, 3
    • additional infection and adjustment dose: 1
    • additional infection and liver injury: 1, 2
    • additional infection and long term treatment: 1
    • additional infection and magnetic resonance: 1
    • adjustment dose and liver injury: 1
    • adjustment dose and long term treatment: 1
    • administration oral route and long term treatment: 1
    • admission lead and lymphocyte count: 1
    • liver injury and long term treatment: 1, 2
    • liver injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • liver injury and magnetic resonance: 1, 2, 3, 4, 5, 6
    • long term treatment and lumbar puncture: 1, 2
    • long term treatment and lymphocyte count: 1
    • long term treatment and magnetic resonance: 1, 2, 3, 4, 5, 6